Albany Molecular says proposed obesity drug is safe

05/31/2011 | RTT News

New York-based Albany Molecular Research announced Tuesday that the firm's obesity compound ALB-127158(a) was safe and well tolerated among overweight participants in an early-stage trial. Experts noted reduced hunger, food cravings and meal consumptions in those who took the drug.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT